New nanoparticle drug combination for atherosclerosis developed
Wednesday, June 17, 2020 - 08:40
in Physics & Chemistry
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.